VistaGen Therapeutics Inc (NASDAQ: VTGN) stock enjoyed a major increase of 10.6% on 10/20/25. The shares closed at $4.48. Moreover, trading volume in this advance was above average at 121% of normal. The stock has been strong relative to the market over the last nine months and has risen 11.2% during the last week.
Current PriceTarget Research Rating
VistaGen Therapeutics has a current Value Trend Rating of D (Negative). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. VistaGen Therapeutics has a very low Appreciation Score of 5 but a slightly positive Power Rating of 69, leading to the Negative Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment